Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

Published:2016-06 Issue: Volume:96 Page:1-6
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Cedrés S.,Ponce-Aix S.,Pardo-Aranda N.,Navarro-Mendivil A.,Martinez-Marti A.,Zugazagoitia J.,Sansano I.,Montoro M.A.,Enguita A.,Felip E.

Funder

Paolo Nuciforo and Jose Jimenez for excellent technical assistance with FFPE and immunohistochemistry

Marta Vilaro for statistical support and Francisco Sánchez Vélez for graphic design

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference51 articles.

1. Pleural mesothelioma;Martini;Ann. Thorac. Surg.,1987

2. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J. Clin. Oncol.,2003

3. Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

4. Induction chemotherapy, extrapleural pneumonectomy, andradiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience;Flores;Lung Cancer,2005

5. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma;de Perrot;J. Clin. Oncol.,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment;Cancer Biotherapy and Radiopharmaceuticals;2024-08-02

2. Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress;Frontiers in Immunology;2023-01-27

3. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project;Modern Pathology;2022-12

4. Tumor accomplice: T cell exhaustion induced by chronic inflammation;Frontiers in Immunology;2022-09-02

5. The Predictive and Prognostic Nature of Programmed Death-Ligand 1 in Malignant Pleural Mesothelioma: A Systematic Literature Review;JTO Clinical and Research Reports;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3